IASO104

· Institute of Hematology & Blood Diseases Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IASO104, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]